If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
559.00    3.00 (0.54%)
Bid:
556.50
Ask:
557.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:31

Tate & Lyle PLC

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that it was informed yesterday that transactions occurred by Persons Discharging Managerial Responsibilities (‘PDMR’) in respect of their interests in ordinary shares of 25 pence each in the capital of the Company (‘Shares’) under the 2016 Conditional Share Award programme (‘CSA’).

No consideration was paid for the acquisition of these Shares. Awards made under the CSA were subject to certain Company-based financial performance criteria satisfied over a performance period which ran from 1 April 2016 to 31 March 2017. The Awards were further subject to a 12-month deferral period and continued employment to 31 March 2018.

Following the withholding of Shares to satisfy certain tax obligations arising on the exercise of nil-cost options or the release of Shares, the PDMR’s interests in Shares changed as detailed in the table below:

PDMR   Date of Transaction   No. of Shares acquired under the CSA
Rowan Adams 4 April 2018 25,144
Joan Braca 3 April 2018 37,814
Jim Stutelberg 3 April 2018 25,170

For tax purposes, the market value of the Shares, being the average of the two close prices on the date of the transaction, was 542.4 pence per Share on 4 April 2018 and 537.6 pence per Share on 3 April 2018.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’Grady Company Secretary 5 April 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Rowan Adams
2. Reason for the notification
a) Position / status PDMR – Executive Vice President, Corporate Affairs
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the exercise of nil-cost options over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,144

d) Aggregated information

 

Aggregated volume Price

25,144 Nil

 

e) Date of the transaction 2017-04-04
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Joan Braca
2. Reason for the notification
a) Position / status PDMR – President, Speciality Food Ingredients
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 37,814

d) Aggregated information

 

Aggregated volume Price

37,814 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Jim Stutelberg
2. Reason for the notification
a) Position / status PDMR – President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,170

d) Aggregated information

 

Aggregated volume Price

25,170 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: https://www.businesswire.com/news/home/20180405005843/en/

Copyright Business Wire 2018

Date   Source Headline
19th Dec 20245:24 pmRNSTransaction in Own Shares
18th Dec 20245:37 pmRNSTransaction in Own Shares
17th Dec 20245:20 pmRNSTransaction in Own Shares
16th Dec 20245:37 pmRNSTransaction in Own Shares
13th Dec 20245:25 pmRNSTransaction in Own Shares
12th Dec 20245:34 pmRNSTransaction in Own Shares
12th Dec 20245:30 pmRNSDirector/PDMR Shareholding
11th Dec 20245:28 pmRNSTransaction in Own Shares
10th Dec 20245:32 pmRNSTransaction in Own Shares
9th Dec 20245:25 pmRNSTransaction in Own Shares
6th Dec 20245:33 pmRNSTransaction in Own Shares
5th Dec 20245:38 pmRNSTransaction in Own Shares
5th Dec 20242:30 pmRNSHolding(s) in Company
5th Dec 20242:00 pmRNSDirector/PDMR Shareholding
4th Dec 20245:32 pmRNSTransaction in Own Shares
4th Dec 20244:00 pmRNSHolding(s) in Company
3rd Dec 20245:21 pmRNSTransaction in Own Shares
3rd Dec 20243:00 pmRNSHolding(s) in Company
2nd Dec 20245:31 pmRNSTransaction in Own Shares
2nd Dec 202412:30 pmRNSTotal Voting Rights
29th Nov 20245:41 pmRNSTransaction in Own Shares
28th Nov 20245:21 pmRNSTransaction in Own Shares
27th Nov 20245:31 pmRNSTransaction in Own Shares
26th Nov 20245:48 pmRNSTransaction in Own Shares
26th Nov 20242:30 pmRNSHolding(s) in Company
25th Nov 20245:09 pmRNSTransaction in Own Shares
22nd Nov 20245:28 pmRNSTransaction in Own Shares
21st Nov 20245:24 pmRNSTransaction in Own Shares
20th Nov 20245:44 pmRNSTransaction in Own Shares
20th Nov 20244:30 pmRNSHolding(s) in Company
19th Nov 20245:33 pmRNSTransaction in Own Shares
19th Nov 20243:15 pmRNSHolding(s) in Company
19th Nov 20243:00 pmRNSHolding(s) in Company
18th Nov 20245:20 pmRNSTransaction in Own Shares
18th Nov 20244:00 pmRNSHolding(s) in Company
18th Nov 20248:30 amRNSDirector/PDMR Shareholding
18th Nov 20248:00 amRNSAdmission of New Tate & Lyle Shares
15th Nov 20245:30 pmRNSTransaction in Own Shares
15th Nov 20243:13 pmRNSCompletion of Combination Tate & Lyle and CP Kelco
14th Nov 20245:48 pmRNSTransaction in Own Shares
13th Nov 20245:16 pmRNSTransaction in Own Shares
12th Nov 20245:45 pmRNSTransaction in Own Shares
11th Nov 20245:37 pmRNSTransaction in Own Shares
8th Nov 20245:29 pmRNSTransaction in Own Shares
7th Nov 20245:31 pmRNSTransaction in Own Shares
7th Nov 20247:00 amRNSHalf-year Report
6th Nov 20245:44 pmRNSTransaction in Own Shares
5th Nov 20245:20 pmRNSTransaction in Own Shares
5th Nov 20241:00 pmRNSHolding(s) in Company
4th Nov 20245:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.